Analyst Ranking
Bottom 1%
#5064 out of 5100 analysts
Average Return
-11.05%
Win Rate
31%61 out of 195
Risk vs Reward
Poor
Good

Michael Petusky's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Lifecore Biomedical IncLFCR
+131.94%$3.10$7.19
2023-03-20 -
2024-03-19
Buy
Opko Health IncOPK
+65.31%$0.99$1.63
2024-02-28 -
2025-02-27
Buy
Lifecore Biomedical IncLFCR
+54.15%$3.25$5.01
2023-03-21 -
2024-03-20
Buy
Haemonetics CorpHAE
+45.09%$50.65$73.49
2025-09-23 -
2025-11-14
Buy
Haemonetics CorpHAE
+43.56%$51.19$73.49
2025-10-21 -
2025-11-14
Buy

Michael Petusky Analyst Color

Get additional color on Michael Petusky's coverage of popular stocks

Michael Petusky's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Merit Medical Systems IncMMSI
25Buy$106.00+24.57%Maintains
2 days ago
Dentsply Sirona IncXRAY
20Buy$14.00+33.08%Maintains
6 days ago
Haemonetics CorpHAE
22Buy$90.00+22.47%Maintains
9 days ago
Anika Therapeutics IncANIK
15Buy$16.00+60.16%Maintains
10 days ago
Henry Schein IncHSIC
18Buy$79.00+10.60%Maintains
11 days ago
Orthofix Medical IncOFIX
4Buy$18.00+20.40%Maintains
11 days ago
Option Care Health IncOPCH
18Buy$38.00+33.76%Maintains
16 days ago
Opko Health IncOPK
11Buy$2.25+75.78%Maintains
17 days ago
U S Physical Therapy IncUSPH
20Buy$103.00+43.71%Maintains
23 days ago
Lemaitre Vascular IncLMAT
11Buy$95.00+7.42%Maintains
a month ago
Verifyme IncVRME
10Buy$1.50+87.73%Maintains
3 months ago
Modivcare IncMODVQ
13Buy$6.00+2,027.66%Maintains
8 months ago
Surmodics IncSRDX
5Buy$71.00N/AMaintains
2 years ago
Lifecore Biomedical IncLFCR
9Buy$10.00N/AMaintains
2 years ago
Ati Physical Therapy IncATIP
1Buy$14.00N/AInitiates Coverage On
4 years ago
Pharmerica CorpPMC
1SellN/AN/ADowngrades
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.